Results 1 to 10 of about 57,137 (207)

Yttrium-90 radiation segmentectomy of oligometastatic urothelial carcinoma. [PDF]

Radiol Case Rep
Many patients with primary or metastatic liver tumors are not surgical candidates or have lesions that are not amenable to thermal ablation. Radiation segmentectomy involves microcatheter delivery of an ablative dose of Yttrium-90 microspheres through ...
Warfield AE, Scriver GM, Kallen J, Massouh AR, Bhave AD, Majdalany BS.   +5 more
europepmc   +2 more sources

Yttrium-90 (⁹⁰Y) brachytherapy for squamous carcinoma: Treatment of the conjunctiva, cornea, and sclera. [PDF]

Am J Ophthalmol Case Rep
Purpose: Patients with conjunctival squamous cell carcinoma that present with persisting disease or recurrence following topical chemotherapy and/or surgery especially when invading the sclera are challenging to treat. Herein, we describe the use of high-
Maniar A, Chino J, Meltsner S, Finger PT, Materin MA.   +4 more
europepmc   +2 more sources

Rapid 90Sr quantification method based on the Bateman equation for routine laboratory work

Nukleonika, 2022
Artificially introduced into the environment 90Sr is highly radiotoxic, so its content levels in foodstuff and biota require constant monitoring for radiological protection.
Wiatr Karol, Rubel Barbara, Kardaś Małgorzata   +2 more
doaj   +1 more source

Comparison of the Biograph Vision and Biograph mCT for quantitative 90Y PET/CT imaging for radioembolisation

EJNMMI Physics, 2020
Background New digital PET scanners with improved time of flight timing and extended axial field of view such as the Siemens Biograph Vision have come on the market and are expected to replace current generation photomultiplier tube (PMT)-based systems ...
Britt Kunnen, Casper Beijst, Marnix G. E. H. Lam, Max A. Viergever, Hugo W. A. M. de Jong   +4 more
doaj   +1 more source

Concepts and methods for the dosimetry of radioembolisation of the liver with Y-90-loaded microspheres

Frontiers in Nuclear Medicine, 2022
This article aims at presenting in a didactic way, dosimetry concepts and methods that are relevant for radio-embolization of the liver with 90Y-microspheres.
Arnaud Dieudonné, Arnaud Dieudonné, Manuel Sanchez-Garcia, Aurélie Bando-Delaunay, Rachida Lebtahi   +4 more
doaj   +1 more source

A Comparison of Techniques for 90Y PET/CT Image-Based Dosimetry following Radioembolization with Resin Microspheres

Frontiers in Oncology, 2014
90Y PET/CT following radioembolization has recently been established as a viable diagnostic tool, capable of producing images that are both quantitative and have superior image quality than alternative 90Y imaging modalities.
Alexander Samuel Pasciak, Alexander Samuel Pasciak, Austin C Bourgeois, Yong C Bradley   +3 more
doaj   +1 more source

Single-Compartment Dose Prescriptions for Ablative ⁹⁰Y-Radioembolization Segmentectomy

Life, 2023
Background: Yttrium-90 (90Y) radioembolization is increasingly being utilized with curative intent. While single-compartment doses with respect to the perfused volume for the complete pathologic necrosis (CPN) of tumors have been reported, the actual ...
Srinivas Cheenu Kappadath, Benjamin P. Lopez   +1 more
doaj   +1 more source

Application of Ion-Exchange Resin Column for Basic Development of Strontium-90/Yttrium-90 Generator for Preparation of Radiopharmaceutical Therapy

Indonesian Journal of Chemistry, 2017
The aim of this study is to examine the possible use of ion-exchange resin on Dowex AG 50x8 in separating Y-90 from Sr-90 which then could be applied in the basic of manufacture of producing Sr-90/Y-90 generator for the production of radiopharmaceutical ...
Muchtaridi Muchtaridi, Elvan Kamal, Anas Subarnas, Abdul Mutalib   +3 more
doaj   +1 more source

Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility

Journal of Interventional Medicine, 2023
Purpose: The IMbrave150 Phase III trial demonstrated the superiority of atezolizumab and bevacizumab (Atezo/Bev) over sorafenib for unresectable hepatocellular carcinoma (HCC).
Qian Yu, Yating Wang, Ethan Ungchusri, Mikin Patel, Divya Kumari, Thuong Van Ha, Anjana Pillai, Chih-yi Liao, Osman Ahmed   +8 more
doaj   +1 more source

Side Effects of Yttrium-90 Radioembolization

Frontiers in Oncology, 2014
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj   +1 more source